Journal: The journal of physical chemistry. B

Article Title: Hematoxylin Inhibits Amyloid ?-Protein Fibrillation and Alleviates Amyloid-Induced Cytotoxicity.

PMID/MRN: 27749059

Publication Date: 2016-Nov-10

Abstract:

Accumulation and aggregation of amyloid ?-protein (A?) play an important role in the pathogenesis of Alzheimer's disease. There has been increased interest in finding new anti-amyloidogenic compounds to inhibit A? aggregation. Herein, thioflavin T fluorescent assay and transmission electron microscopy results showed that hematoxylin, a natural organic molecule extracted from Caesalpinia sappan, was a powerful inhibitor of A?42 fibrillogenesis. Circular dichroism studies revealed hematoxylin reduced the ?-sheet content of A?42 and made it assemble into antiparallel arrangement, which induced A?42 to form off-pathway aggregates. As a result, hematoxylin greatly alleviated A?42-induced cytotoxicity. Molecular dynamics simulations revealed the detailed interactions between hematoxylin and A?42. Four binding sites of hematoxylin on A?42 hexamer were identified, including the N-terminal region, S8GY10 region, turn region, and C-terminal region. Notably, abundant hydroxyl groups made hematoxylin prefer to interact with A?42 via hydrogen bonds. This also contributed to the formation of ¹-¹ stacking and hydrophobic interactions. Taken together, the research proved that hematoxylin was a potential agent against A? fibrillogenesis and cytotoxicity.